Daewoong Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daewoong Company Limited with three other
companies in this sector in South Korea:
Hanmi Pharmaceutical., Company Limited
sales of 1.02 trillion Korean Won [US$875.76 million]
of which 78%
Kwang Dong Pharmaceutical Company Limited
(1.18 trillion Korean Won [US$1.02 billion]
of which 42%
was MRO), and
Daewoong Pharmaceutical Company Limited
(1.03 trillion Korean Won [US$889.09 million]
of which 103%
was Medicine Manufacture&Sale).
During the year ended December of 2018, sales at
Daewoong Company Limited were 1.23 trillion Korean Won (US$1.06 billion).
increase of 9.5%
versus 2017, when the company's sales were 1.12 trillion Korean Won.
This was the fifth consecutive year of sales increases at Daewoong Company Limited
(and since 2013, sales have increased a total of 46%).
Sales of Other saw an increase
11.8% in 2018, from
2.87 billion Korean Won to 3.21 billion Korean Won.
Not all segments of Daewoong Company Limited experienced an increase in sales in 2018:
sales of Services fell 9.3% to 69.13 billion Korean Won.